Literature DB >> 3285702

A carbamazepine trial in chronic, treatment-refractory schizophrenia.

J Sramek1, J Herrera, J Costa, C Heh, T Tran-Johnson, G Simpson.   

Abstract

Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285702     DOI: 10.1176/ajp.145.6.748

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  3 in total

1.  Asterixis as a side effect of carbamazepine therapy.

Authors:  H Rittmannsberger; F Leblhuber; R Sommer
Journal:  Klin Wochenschr       Date:  1991-04-04

Review 2.  The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Authors:  C Simhandl; K Meszaros
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

Review 3.  Carbamazepine for schizophrenia.

Authors:  Stefan Leucht; Bartosz Helfer; Markus Dold; Werner Kissling; John McGrath
Journal:  Cochrane Database Syst Rev       Date:  2014-05-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.